These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 16981980)

  • 41. Allergic contact dermatitis from transdermal buprenorphine.
    Vander Hulst K; Parera Amer E; Jacobs C; Dewulf V; Baeck M; Pujol Vallverdú RM; Giménez-Arnau A; Tennstedt D; Goossens A
    Contact Dermatitis; 2008 Dec; 59(6):366-9. PubMed ID: 19076888
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Transdermal buprenorphine in children with cancer-related pain.
    Attinà G; Ruggiero A; Maurizi P; Arlotta A; Chiaretti A; Riccardi R
    Pediatr Blood Cancer; 2009 Jan; 52(1):125-7. PubMed ID: 18802942
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Transdermal buprenorphine for the treatment of moderate to severe chronic pain: results from a large multicenter, non-interventional post-marketing study in Poland.
    Przeklasa-Muszynska A; Dobrogowski J
    Curr Med Res Opin; 2011 Jun; 27(6):1109-17. PubMed ID: 21456888
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Differential sensitivity of three experimental pain models in detecting the analgesic effects of transdermal fentanyl and buprenorphine.
    Koltzenburg M; Pokorny R; Gasser UE; Richarz U
    Pain; 2006 Dec; 126(1-3):165-74. PubMed ID: 16901645
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Application of a seven-day buprenorphine transdermal patch in multimorbid patients on long-term ibuprofen or diclofenac].
    Böhme K; Heckes B; Thomitzek K
    MMW Fortschr Med; 2011 Jan; 152 Suppl 4():125-32. PubMed ID: 21598463
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Introduction of low dose transdermal buprenorphine -- did it influence use of potentially addictive drugs in chronic non-malignant pain patients?
    Skurtveit S; Furu K; Kaasa S; Borchgrevink PC
    Eur J Pain; 2009 Oct; 13(9):949-53. PubMed ID: 19095476
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A randomized, double-blind, double-dummy comparison of the efficacy and tolerability of low-dose transdermal buprenorphine (BuTrans seven-day patches) with buprenorphine sublingual tablets (Temgesic) in patients with osteoarthritis pain.
    James IG; O'Brien CM; McDonald CJ
    J Pain Symptom Manage; 2010 Aug; 40(2):266-78. PubMed ID: 20541900
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Effects of transdermal buprenorphine in cancer patients. Results from the Cancer Pain Outcome Research (CPOR) Study Group].
    Greco MT; Deandrea S; Corli O; Montanari M; Caraceni A; Apolone G;
    Recenti Prog Med; 2008 Nov; 99(11):538-51. PubMed ID: 19209537
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Transdermal buprenorphine controls central neuropathic pain.
    Weiner M; Sarantopoulos C; Gordon E
    J Opioid Manag; 2012; 8(6):414-5. PubMed ID: 23264319
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of intravenous patient-controlled analgesia with buprenorphine and morphine alone and in combination during the first 12 postoperative hours: a randomized, double-blind, four-arm trial in adults undergoing abdominal surgery.
    Oifa S; Sydoruk T; White I; Ekstein MP; Marouani N; Chazan S; Skornick Y; Weinbroum AA
    Clin Ther; 2009 Mar; 31(3):527-41. PubMed ID: 19393843
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Efficacy and safety of buprenorphine transdermal system (BTDS) for chronic moderate to severe low back pain: a randomized, double-blind study.
    Steiner D; Munera C; Hale M; Ripa S; Landau C
    J Pain; 2011 Nov; 12(11):1163-73. PubMed ID: 21807566
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Buprenorphine transdermal system in adults with chronic low back pain: a randomized, double-blind, placebo-controlled crossover study, followed by an open-label extension phase.
    Gordon A; Callaghan D; Spink D; Cloutier C; Dzongowski P; O'Mahony W; Sinclair D; Rashiq S; Buckley N; Cohen G; Kim J; Boulanger A; Piraino PS; Eisenhoffer J; Harsanyi Z; Darke AC; Michalko KJ
    Clin Ther; 2010 May; 32(5):844-60. PubMed ID: 20685494
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Buprenorphine 5, 10 and 20 μg/h transdermal patch: a review of its use in the management of chronic non-malignant pain.
    Plosker GL
    Drugs; 2011 Dec; 71(18):2491-509. PubMed ID: 22141389
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A comparison of the skin irritation potential of transdermal fentanyl versus transdermal buprenorphine in middle-aged to elderly healthy volunteers.
    Schmid-Grendelmeier P; Pokorny R; Gasser UE; Richarz U
    Curr Med Res Opin; 2006 Mar; 22(3):501-9. PubMed ID: 16574034
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Buprenorphine transdermal patch (Norspan tape)].
    Hamaguchi S; Ikeda T
    Masui; 2013 Jul; 62(7):799-807. PubMed ID: 23905402
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Assessing cognitive and psychomotor performance under long-term treatment with transdermal buprenorphine in chronic noncancer pain patients.
    Dagtekin O; Gerbershagen HJ; Wagner W; Petzke F; Radbruch L; Sabatowski R
    Anesth Analg; 2007 Nov; 105(5):1442-8, table of contents. PubMed ID: 17959980
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Frequency, indications, outcomes, and predictive factors of opioid switching in an acute palliative care unit.
    Mercadante S; Ferrera P; Villari P; Casuccio A; Intravaia G; Mangione S
    J Pain Symptom Manage; 2009 Apr; 37(4):632-41. PubMed ID: 19345298
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Efficacy and safety of transdermal buprenorphine in the management of children with cancer-related pain.
    Ruggiero A; Coccia P; Arena R; Maurizi P; Battista A; Ridola V; Attinà G; Riccardi R
    Pediatr Blood Cancer; 2013 Mar; 60(3):433-7. PubMed ID: 23034996
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Transdermal buprenorphine in chronic pain: indications and clinical experience.
    Kusnik S; Likar R; Sittl R
    Expert Rev Clin Pharmacol; 2008 Nov; 1(6):729-36. PubMed ID: 24410602
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The unique role of transdermal buprenorphine in the global chronic pain epidemic.
    Pergolizzi JV; Scholten W; Smith KJ; Leighton-Scott J; Willis JC; Henningfield JE
    Acta Anaesthesiol Taiwan; 2015 Jun; 53(2):71-6. PubMed ID: 26205326
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.